Review




Structured Review

Galectin Therapeutics galectin 8l high mantle zone rim
(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, <t>and</t> <t>Galectin-8L</t> across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.
Galectin 8l High Mantle Zone Rim, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+8l+high+mantle+zone+rim/bio_rxiv__64898__2026__02__23__707224-214-14-14?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
galectin 8l high mantle zone rim - by Bioz Stars, 2026-08
86/100 stars

Images

1) Product Images from "Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues"

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

Journal: bioRxiv

doi: 10.64898/2026.02.23.707224

(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, and Galectin-8L across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.
Figure Legend Snippet: (A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, and Galectin-8L across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.

Techniques Used: Expressing, Marker, Binding Assay, Functional Assay, Gene Expression, Activation Assay, Glycoproteomics

(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B) Violin plots depicting log-normalized expression of lectin-binding ligands for DC-SIGNL, Galectin-8L, MBL-L and Siglec-15L across cell types and perturbations. (C) Expression and clustering of O-glycosylation related genes across different cell types and conditions. (D) Heatmap of key functional CD4+ T gene expression across perturbations. (E) GSEA analyses across CD4+ T between LPS stimulation with anti-Siglec7 and anti-Siglec9 blocking antibodies compared to LPS treatment alone.
Figure Legend Snippet: (A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B) Violin plots depicting log-normalized expression of lectin-binding ligands for DC-SIGNL, Galectin-8L, MBL-L and Siglec-15L across cell types and perturbations. (C) Expression and clustering of O-glycosylation related genes across different cell types and conditions. (D) Heatmap of key functional CD4+ T gene expression across perturbations. (E) GSEA analyses across CD4+ T between LPS stimulation with anti-Siglec7 and anti-Siglec9 blocking antibodies compared to LPS treatment alone.

Techniques Used: Expressing, Marker, Binding Assay, Glycoproteomics, Functional Assay, Gene Expression, Blocking Assay

(A) Schematic workflow of GlycoScope, illustrating the sequential staining of antibody and recombinant lectin panels. (B) Representative multiplexed images showing nuclei (DAPI), Siglec-9L, Siglec-15L, Galectin-8L, T cells (CD3), B cells (CD20), and follicular dendritic cells (CD21) across GlycoScope, Antibody-only, and Lectin-only conditions of tonsil tissues (scale bar: 50µm, 10µm (inset)). All individual images across these three conditions are in . (C) Heatmap showing the 0,1 normalization of mean expression (left) and z-score of the coefficient of variation (right) of all glycan and protein markers obtained from GlycoScope, Antibody-only, and Lectin-only conditions. (D) Schematic overview of the GlycoScope study cohorts. Cohort 1 consists of an FFPE tissue microarray (TMA) containing four tonsil, four follicular hyperplasia (FH), and eight follicular lymphoma (FL) cores, profiled using a 32-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, MBL, DC-SIGN, and Galectin-8). Cohort 2 consists of an FFPE TMA containing 11 FL and 5 FH samples, profiled using a 42-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, DC-SIGN, Galectin-8, and Galectin-9). (E) Representative GlycoScope multiplexed images (top) showing nuclei (DAPI), B/tumor cells (Pax5), macro-phages (CD68), T cells (CD3), endothelial cells (CD31), FDC-enriched region (CD21) and lymphatic (Podoplanin), as well as the corresponding phenotype maps (bottom) of FL, FH and tonsil tissues (scale bar: 100µm, 20µm (inset)). All individual phenotype maps for each tissue sample core are in . (F) Top: Representative GlycoScope multiplexed images of FL and FH showing Siglec-7L (magenta), CD31 (yellow), and PAX5 (cyan). Bottom: Representative GlycoScope multiplexed images of FL and FH showing Siglec-9L (cyan), CD31 (magenta), and PAX5 (white). Scale bar, 100 µm. (G) Representative GlycoScope multiplexed images of FL and FH showing DC-SIGNL (cyan), CD21 (magenta) and CD21 (yellow). scale bar: 100µm. (H) Violin plots showing the expression of DC-SIGNL acquired from GlycoScope in tonsil, FH and FL tissues (Krus-kal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (I) Histogram showing the expression distribution of DC-SIGNL in B cell. (J) Violin plots showing the expression of BCL2 protein in DC-SIGNL High and DC-SIGNL Low B cells (Pairwise Wilcoxon test). (K) Line plot showing the mean expression of DC-SIGNL in follicle B cell at 0-150 µm from the anchored FDC. ***P<0.001; ****P<0.0001
Figure Legend Snippet: (A) Schematic workflow of GlycoScope, illustrating the sequential staining of antibody and recombinant lectin panels. (B) Representative multiplexed images showing nuclei (DAPI), Siglec-9L, Siglec-15L, Galectin-8L, T cells (CD3), B cells (CD20), and follicular dendritic cells (CD21) across GlycoScope, Antibody-only, and Lectin-only conditions of tonsil tissues (scale bar: 50µm, 10µm (inset)). All individual images across these three conditions are in . (C) Heatmap showing the 0,1 normalization of mean expression (left) and z-score of the coefficient of variation (right) of all glycan and protein markers obtained from GlycoScope, Antibody-only, and Lectin-only conditions. (D) Schematic overview of the GlycoScope study cohorts. Cohort 1 consists of an FFPE tissue microarray (TMA) containing four tonsil, four follicular hyperplasia (FH), and eight follicular lymphoma (FL) cores, profiled using a 32-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, MBL, DC-SIGN, and Galectin-8). Cohort 2 consists of an FFPE TMA containing 11 FL and 5 FH samples, profiled using a 42-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, DC-SIGN, Galectin-8, and Galectin-9). (E) Representative GlycoScope multiplexed images (top) showing nuclei (DAPI), B/tumor cells (Pax5), macro-phages (CD68), T cells (CD3), endothelial cells (CD31), FDC-enriched region (CD21) and lymphatic (Podoplanin), as well as the corresponding phenotype maps (bottom) of FL, FH and tonsil tissues (scale bar: 100µm, 20µm (inset)). All individual phenotype maps for each tissue sample core are in . (F) Top: Representative GlycoScope multiplexed images of FL and FH showing Siglec-7L (magenta), CD31 (yellow), and PAX5 (cyan). Bottom: Representative GlycoScope multiplexed images of FL and FH showing Siglec-9L (cyan), CD31 (magenta), and PAX5 (white). Scale bar, 100 µm. (G) Representative GlycoScope multiplexed images of FL and FH showing DC-SIGNL (cyan), CD21 (magenta) and CD21 (yellow). scale bar: 100µm. (H) Violin plots showing the expression of DC-SIGNL acquired from GlycoScope in tonsil, FH and FL tissues (Krus-kal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (I) Histogram showing the expression distribution of DC-SIGNL in B cell. (J) Violin plots showing the expression of BCL2 protein in DC-SIGNL High and DC-SIGNL Low B cells (Pairwise Wilcoxon test). (K) Line plot showing the mean expression of DC-SIGNL in follicle B cell at 0-150 µm from the anchored FDC. ***P<0.001; ****P<0.0001

Techniques Used: Staining, Recombinant, Expressing, Glycoproteomics, Microarray

(A) Violin plots showing the median expression of Galectin-8L across cell types (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (B) Representative GlycoScope multiplexed images with markers for Galectin-8L and B cells (Pax5) shown (scale bar: 20µm). (C) Violin plots showing the mean expression of Galectin-8L in B cells within the follicle across tonsil, FH, and FL tissues (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Mean expression of Galectin-8L in BCL6+, BCL2+, and neo-plastic BCL2+BCL6+ follicular B cells across tonsil, FH, and FL tissues. (E) Representative GlycoScope multiplexed images with markers for Galectin-8L (green), BCL6 (pink), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (F) Representative GlycoScope multiplexed images with markers for Galectin-9L (magenta), BCL6 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for follicle center and neoplastic follicle. (G) Representative GlycoScope multiplexed images with markers for Galectin-8L (magenta), Galectin-8 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (H) Schematic illustration of stepwise extension analysis. Galectin-8L+ B cells at the mantle-marginal zone rim were anchored and expanded inward towards the follicle center (blue) and outward towards marginal zone (red), in 10 µm radial steps. (I) Mean proportions of Treg between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown. The region in grey symbolizes the follicle. Mean proportions of FDC-enriched B cells, CD4+ T, CD8+ T, CD68+ macrophage and CD68+CD163+ macrophages are shown in (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (J) Mean expression of Galectin-8L in follicular B cells at each step across tonsil, FH, and FL tissues. (K) Correlation scatter plot of the proportion of PD1+ (left) and Tox1/2+ (right) T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (L) Top: Correlation scatter plot of the proportion of CD3T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim). Bottom: Correlation scatter plot of the proportion of Tox1/2+ or PD1+ T cells with BCL2 expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (M) Schematic illustration of summary findings. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns P>0.05.
Figure Legend Snippet: (A) Violin plots showing the median expression of Galectin-8L across cell types (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (B) Representative GlycoScope multiplexed images with markers for Galectin-8L and B cells (Pax5) shown (scale bar: 20µm). (C) Violin plots showing the mean expression of Galectin-8L in B cells within the follicle across tonsil, FH, and FL tissues (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Mean expression of Galectin-8L in BCL6+, BCL2+, and neo-plastic BCL2+BCL6+ follicular B cells across tonsil, FH, and FL tissues. (E) Representative GlycoScope multiplexed images with markers for Galectin-8L (green), BCL6 (pink), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (F) Representative GlycoScope multiplexed images with markers for Galectin-9L (magenta), BCL6 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for follicle center and neoplastic follicle. (G) Representative GlycoScope multiplexed images with markers for Galectin-8L (magenta), Galectin-8 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (H) Schematic illustration of stepwise extension analysis. Galectin-8L+ B cells at the mantle-marginal zone rim were anchored and expanded inward towards the follicle center (blue) and outward towards marginal zone (red), in 10 µm radial steps. (I) Mean proportions of Treg between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown. The region in grey symbolizes the follicle. Mean proportions of FDC-enriched B cells, CD4+ T, CD8+ T, CD68+ macrophage and CD68+CD163+ macrophages are shown in (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (J) Mean expression of Galectin-8L in follicular B cells at each step across tonsil, FH, and FL tissues. (K) Correlation scatter plot of the proportion of PD1+ (left) and Tox1/2+ (right) T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (L) Top: Correlation scatter plot of the proportion of CD3T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim). Bottom: Correlation scatter plot of the proportion of Tox1/2+ or PD1+ T cells with BCL2 expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (M) Schematic illustration of summary findings. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns P>0.05.

Techniques Used: Expressing

(A) Additional multiplexed images of tonsil, FH and FL cores showing Galectin-8L (green), BCL6 (pink) and CD3 (cyan) markers (scale bar: 20µm). (B) Mean proportions of FDC-enriched B cells between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (C) Mean proportions of CD8+ T (top left), CD4+ T (top right), CD68+ Macrophage (bottom, left) and CD68+ CD163+Macrophage (bottom right), between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Correlation scatter plot of the proportion of LAG3+ (left) and TIM3+ (right) T cells with Galectin-8L expression in B cells at each step within the follicle (Spearman’s correlation with Benjamini-Hochberg adjustments). *P<0.05; **P<0.01; ****P<0.0001; ns P>0.05.
Figure Legend Snippet: (A) Additional multiplexed images of tonsil, FH and FL cores showing Galectin-8L (green), BCL6 (pink) and CD3 (cyan) markers (scale bar: 20µm). (B) Mean proportions of FDC-enriched B cells between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (C) Mean proportions of CD8+ T (top left), CD4+ T (top right), CD68+ Macrophage (bottom, left) and CD68+ CD163+Macrophage (bottom right), between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Correlation scatter plot of the proportion of LAG3+ (left) and TIM3+ (right) T cells with Galectin-8L expression in B cells at each step within the follicle (Spearman’s correlation with Benjamini-Hochberg adjustments). *P<0.05; **P<0.01; ****P<0.0001; ns P>0.05.

Techniques Used: Expressing



Similar Products

86
Galectin Therapeutics galectin 8l high mantle zone rim
(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, <t>and</t> <t>Galectin-8L</t> across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.
Galectin 8l High Mantle Zone Rim, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+8l+high+mantle+zone+rim/bio_rxiv__64898__2026__02__23__707224-214-14-14?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
galectin 8l high mantle zone rim - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, and Galectin-8L across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.

Journal: bioRxiv

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

doi: 10.64898/2026.02.23.707224

Figure Lengend Snippet: (A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B-C) Violin plots depicting log-normalized expression of lectin-binding ligands for Siglec-7L, Siglec-9L, Siglec-15L, DC-SIGNL, and Galectin-8L across cell types and perturbations. (D) Scatter density plot showing different populations of TCR stimulated CD8+ T cells and NK cells binned by expression levels of Siglec-9L and Siglec-15L. (E) Heatmap of key functional CD8+ T cell and NK cell gene expression across TCR stimulated CD8+ T cells and NK cells grouped by expression levels of Siglec-9L and Siglec-15L. (F) Heatmap showing Pearson correlation of functional CD8+ T cell activation genes with Siglec-7L, Siglec9L and Siglec-15L (top) and their expression across CD8+ T cells in different perturbations (bottom). (G) Expression and clustering of different lectin-ligands across different cell types and conditions. (H) Expression and clustering of O-glycosylation related genes across different cell types and conditions.

Article Snippet: We defined the follicular center as the region located 80-150 μm inward from the Galectin-8L High mantle zone rim, the mantle zone as spanning 0-80 μm, and the marginal zone as extending outward of the rim.

Techniques: Expressing, Marker, Binding Assay, Functional Assay, Gene Expression, Activation Assay, Glycoproteomics

(A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B) Violin plots depicting log-normalized expression of lectin-binding ligands for DC-SIGNL, Galectin-8L, MBL-L and Siglec-15L across cell types and perturbations. (C) Expression and clustering of O-glycosylation related genes across different cell types and conditions. (D) Heatmap of key functional CD4+ T gene expression across perturbations. (E) GSEA analyses across CD4+ T between LPS stimulation with anti-Siglec7 and anti-Siglec9 blocking antibodies compared to LPS treatment alone.

Journal: bioRxiv

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

doi: 10.64898/2026.02.23.707224

Figure Lengend Snippet: (A) Dot plot showing the expression of different marker genes used for cell type annotation across different cell types. (B) Violin plots depicting log-normalized expression of lectin-binding ligands for DC-SIGNL, Galectin-8L, MBL-L and Siglec-15L across cell types and perturbations. (C) Expression and clustering of O-glycosylation related genes across different cell types and conditions. (D) Heatmap of key functional CD4+ T gene expression across perturbations. (E) GSEA analyses across CD4+ T between LPS stimulation with anti-Siglec7 and anti-Siglec9 blocking antibodies compared to LPS treatment alone.

Article Snippet: We defined the follicular center as the region located 80-150 μm inward from the Galectin-8L High mantle zone rim, the mantle zone as spanning 0-80 μm, and the marginal zone as extending outward of the rim.

Techniques: Expressing, Marker, Binding Assay, Glycoproteomics, Functional Assay, Gene Expression, Blocking Assay

(A) Schematic workflow of GlycoScope, illustrating the sequential staining of antibody and recombinant lectin panels. (B) Representative multiplexed images showing nuclei (DAPI), Siglec-9L, Siglec-15L, Galectin-8L, T cells (CD3), B cells (CD20), and follicular dendritic cells (CD21) across GlycoScope, Antibody-only, and Lectin-only conditions of tonsil tissues (scale bar: 50µm, 10µm (inset)). All individual images across these three conditions are in . (C) Heatmap showing the 0,1 normalization of mean expression (left) and z-score of the coefficient of variation (right) of all glycan and protein markers obtained from GlycoScope, Antibody-only, and Lectin-only conditions. (D) Schematic overview of the GlycoScope study cohorts. Cohort 1 consists of an FFPE tissue microarray (TMA) containing four tonsil, four follicular hyperplasia (FH), and eight follicular lymphoma (FL) cores, profiled using a 32-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, MBL, DC-SIGN, and Galectin-8). Cohort 2 consists of an FFPE TMA containing 11 FL and 5 FH samples, profiled using a 42-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, DC-SIGN, Galectin-8, and Galectin-9). (E) Representative GlycoScope multiplexed images (top) showing nuclei (DAPI), B/tumor cells (Pax5), macro-phages (CD68), T cells (CD3), endothelial cells (CD31), FDC-enriched region (CD21) and lymphatic (Podoplanin), as well as the corresponding phenotype maps (bottom) of FL, FH and tonsil tissues (scale bar: 100µm, 20µm (inset)). All individual phenotype maps for each tissue sample core are in . (F) Top: Representative GlycoScope multiplexed images of FL and FH showing Siglec-7L (magenta), CD31 (yellow), and PAX5 (cyan). Bottom: Representative GlycoScope multiplexed images of FL and FH showing Siglec-9L (cyan), CD31 (magenta), and PAX5 (white). Scale bar, 100 µm. (G) Representative GlycoScope multiplexed images of FL and FH showing DC-SIGNL (cyan), CD21 (magenta) and CD21 (yellow). scale bar: 100µm. (H) Violin plots showing the expression of DC-SIGNL acquired from GlycoScope in tonsil, FH and FL tissues (Krus-kal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (I) Histogram showing the expression distribution of DC-SIGNL in B cell. (J) Violin plots showing the expression of BCL2 protein in DC-SIGNL High and DC-SIGNL Low B cells (Pairwise Wilcoxon test). (K) Line plot showing the mean expression of DC-SIGNL in follicle B cell at 0-150 µm from the anchored FDC. ***P<0.001; ****P<0.0001

Journal: bioRxiv

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

doi: 10.64898/2026.02.23.707224

Figure Lengend Snippet: (A) Schematic workflow of GlycoScope, illustrating the sequential staining of antibody and recombinant lectin panels. (B) Representative multiplexed images showing nuclei (DAPI), Siglec-9L, Siglec-15L, Galectin-8L, T cells (CD3), B cells (CD20), and follicular dendritic cells (CD21) across GlycoScope, Antibody-only, and Lectin-only conditions of tonsil tissues (scale bar: 50µm, 10µm (inset)). All individual images across these three conditions are in . (C) Heatmap showing the 0,1 normalization of mean expression (left) and z-score of the coefficient of variation (right) of all glycan and protein markers obtained from GlycoScope, Antibody-only, and Lectin-only conditions. (D) Schematic overview of the GlycoScope study cohorts. Cohort 1 consists of an FFPE tissue microarray (TMA) containing four tonsil, four follicular hyperplasia (FH), and eight follicular lymphoma (FL) cores, profiled using a 32-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, MBL, DC-SIGN, and Galectin-8). Cohort 2 consists of an FFPE TMA containing 11 FL and 5 FH samples, profiled using a 42-plex protein panel and six oligo-conjugated lectins (Siglec-7, Siglec-9, Siglec-15, DC-SIGN, Galectin-8, and Galectin-9). (E) Representative GlycoScope multiplexed images (top) showing nuclei (DAPI), B/tumor cells (Pax5), macro-phages (CD68), T cells (CD3), endothelial cells (CD31), FDC-enriched region (CD21) and lymphatic (Podoplanin), as well as the corresponding phenotype maps (bottom) of FL, FH and tonsil tissues (scale bar: 100µm, 20µm (inset)). All individual phenotype maps for each tissue sample core are in . (F) Top: Representative GlycoScope multiplexed images of FL and FH showing Siglec-7L (magenta), CD31 (yellow), and PAX5 (cyan). Bottom: Representative GlycoScope multiplexed images of FL and FH showing Siglec-9L (cyan), CD31 (magenta), and PAX5 (white). Scale bar, 100 µm. (G) Representative GlycoScope multiplexed images of FL and FH showing DC-SIGNL (cyan), CD21 (magenta) and CD21 (yellow). scale bar: 100µm. (H) Violin plots showing the expression of DC-SIGNL acquired from GlycoScope in tonsil, FH and FL tissues (Krus-kal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (I) Histogram showing the expression distribution of DC-SIGNL in B cell. (J) Violin plots showing the expression of BCL2 protein in DC-SIGNL High and DC-SIGNL Low B cells (Pairwise Wilcoxon test). (K) Line plot showing the mean expression of DC-SIGNL in follicle B cell at 0-150 µm from the anchored FDC. ***P<0.001; ****P<0.0001

Article Snippet: We defined the follicular center as the region located 80-150 μm inward from the Galectin-8L High mantle zone rim, the mantle zone as spanning 0-80 μm, and the marginal zone as extending outward of the rim.

Techniques: Staining, Recombinant, Expressing, Glycoproteomics, Microarray

(A) Violin plots showing the median expression of Galectin-8L across cell types (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (B) Representative GlycoScope multiplexed images with markers for Galectin-8L and B cells (Pax5) shown (scale bar: 20µm). (C) Violin plots showing the mean expression of Galectin-8L in B cells within the follicle across tonsil, FH, and FL tissues (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Mean expression of Galectin-8L in BCL6+, BCL2+, and neo-plastic BCL2+BCL6+ follicular B cells across tonsil, FH, and FL tissues. (E) Representative GlycoScope multiplexed images with markers for Galectin-8L (green), BCL6 (pink), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (F) Representative GlycoScope multiplexed images with markers for Galectin-9L (magenta), BCL6 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for follicle center and neoplastic follicle. (G) Representative GlycoScope multiplexed images with markers for Galectin-8L (magenta), Galectin-8 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (H) Schematic illustration of stepwise extension analysis. Galectin-8L+ B cells at the mantle-marginal zone rim were anchored and expanded inward towards the follicle center (blue) and outward towards marginal zone (red), in 10 µm radial steps. (I) Mean proportions of Treg between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown. The region in grey symbolizes the follicle. Mean proportions of FDC-enriched B cells, CD4+ T, CD8+ T, CD68+ macrophage and CD68+CD163+ macrophages are shown in (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (J) Mean expression of Galectin-8L in follicular B cells at each step across tonsil, FH, and FL tissues. (K) Correlation scatter plot of the proportion of PD1+ (left) and Tox1/2+ (right) T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (L) Top: Correlation scatter plot of the proportion of CD3T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim). Bottom: Correlation scatter plot of the proportion of Tox1/2+ or PD1+ T cells with BCL2 expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (M) Schematic illustration of summary findings. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns P>0.05.

Journal: bioRxiv

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

doi: 10.64898/2026.02.23.707224

Figure Lengend Snippet: (A) Violin plots showing the median expression of Galectin-8L across cell types (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (B) Representative GlycoScope multiplexed images with markers for Galectin-8L and B cells (Pax5) shown (scale bar: 20µm). (C) Violin plots showing the mean expression of Galectin-8L in B cells within the follicle across tonsil, FH, and FL tissues (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Mean expression of Galectin-8L in BCL6+, BCL2+, and neo-plastic BCL2+BCL6+ follicular B cells across tonsil, FH, and FL tissues. (E) Representative GlycoScope multiplexed images with markers for Galectin-8L (green), BCL6 (pink), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (F) Representative GlycoScope multiplexed images with markers for Galectin-9L (magenta), BCL6 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for follicle center and neoplastic follicle. (G) Representative GlycoScope multiplexed images with markers for Galectin-8L (magenta), Galectin-8 (yellow), and CD3 (cyan) shown (scale bar: 100µm). White dotted lines marked the regions for mantle zone, follicle center and neoplastic follicle. (H) Schematic illustration of stepwise extension analysis. Galectin-8L+ B cells at the mantle-marginal zone rim were anchored and expanded inward towards the follicle center (blue) and outward towards marginal zone (red), in 10 µm radial steps. (I) Mean proportions of Treg between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown. The region in grey symbolizes the follicle. Mean proportions of FDC-enriched B cells, CD4+ T, CD8+ T, CD68+ macrophage and CD68+CD163+ macrophages are shown in (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (J) Mean expression of Galectin-8L in follicular B cells at each step across tonsil, FH, and FL tissues. (K) Correlation scatter plot of the proportion of PD1+ (left) and Tox1/2+ (right) T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (L) Top: Correlation scatter plot of the proportion of CD3T cells with Galectin-8L expression in B cells at each step (distance towards follicle center from anchor rim). Bottom: Correlation scatter plot of the proportion of Tox1/2+ or PD1+ T cells with BCL2 expression in B cells at each step (distance towards follicle center from anchor rim) (Spearman’s correlation; p-value adjusted with Benjamini-Hochberg method). (M) Schematic illustration of summary findings. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns P>0.05.

Article Snippet: We defined the follicular center as the region located 80-150 μm inward from the Galectin-8L High mantle zone rim, the mantle zone as spanning 0-80 μm, and the marginal zone as extending outward of the rim.

Techniques: Expressing

(A) Additional multiplexed images of tonsil, FH and FL cores showing Galectin-8L (green), BCL6 (pink) and CD3 (cyan) markers (scale bar: 20µm). (B) Mean proportions of FDC-enriched B cells between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (C) Mean proportions of CD8+ T (top left), CD4+ T (top right), CD68+ Macrophage (bottom, left) and CD68+ CD163+Macrophage (bottom right), between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Correlation scatter plot of the proportion of LAG3+ (left) and TIM3+ (right) T cells with Galectin-8L expression in B cells at each step within the follicle (Spearman’s correlation with Benjamini-Hochberg adjustments). *P<0.05; **P<0.01; ****P<0.0001; ns P>0.05.

Journal: bioRxiv

Article Title: Single-Cell and Spatial Methods for Multimodal Functional Glycan Profiling in Tissues

doi: 10.64898/2026.02.23.707224

Figure Lengend Snippet: (A) Additional multiplexed images of tonsil, FH and FL cores showing Galectin-8L (green), BCL6 (pink) and CD3 (cyan) markers (scale bar: 20µm). (B) Mean proportions of FDC-enriched B cells between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (C) Mean proportions of CD8+ T (top left), CD4+ T (top right), CD68+ Macrophage (bottom, left) and CD68+ CD163+Macrophage (bottom right), between 0-140µm towards the follicle center and marginal zone from the anchor rim are shown (Kruskal-Wallis rank sum test followed by pairwise Wilcoxon test with Benjamini-Hochberg adjustments). (D) Correlation scatter plot of the proportion of LAG3+ (left) and TIM3+ (right) T cells with Galectin-8L expression in B cells at each step within the follicle (Spearman’s correlation with Benjamini-Hochberg adjustments). *P<0.05; **P<0.01; ****P<0.0001; ns P>0.05.

Article Snippet: We defined the follicular center as the region located 80-150 μm inward from the Galectin-8L High mantle zone rim, the mantle zone as spanning 0-80 μm, and the marginal zone as extending outward of the rim.

Techniques: Expressing